Anbio Biotechnology — Company profile
Healthcare · Medical Instruments & Supplies · Germany
Last price 3.72 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 163.28M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, SHA dry chemistry, chemiluminescence immunoassay, and real-time polymerase chain reaction solutions; and SARS-CoV-2 and SARS-CoV-2/Flu A/Flu B antigen rapid test kits. It serves over-the-counter, point-of-care testing, and laboratory markets. Anbio Biotechnology was incorporated in 2021 and is based in Frankfurt am Main, Germany.
Details
| Name | Anbio Biotechnology |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Employees | 27 |
| Founded | 2021 |
| Ipo Date | 2025-02-19 |
| Ceo | Michael Lau |
| Country | Germany |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 5.00 |
| Isin | KYG0367B1059 |
| Cusip | G0367B105 |
| Cik | 1982708 |
| Sic | 2835 |
| Share Class | Class A Shares |
Key executives
| Name | Title |
|---|---|
| Michael Lau M.B.A., Ph.D. | Chief Executive Officer |
| Suki Song CPA | Chief Financial Officer |
| Chris Tian | Chief Business Officer |
Contact
| Address | Friedrich-Ebert-Anlage 35-37, Frankfurt am Main, 60327, Germany |
| Phone | 49 698 7003 9170 |
| Website | https://www.anbiobiotechnology.com |